Skip to Main Content

Dubai Health Authority - هيئة الصحة دبي

Text Resize

Use the buttons below to increase or decrease the text size

Contrast switch

Use the toggle below to switch the contrast.

SCREEN READER

Listen to the content of the page by clicking play on ReadSpeaker.

Access

To discover more about accessibility, view our Accessibility Options here

Dubai Health Authority - هيئة الصحة دبي

Text Resize

Use the buttons below to increase or decrease the text size

Contrast switch

Use the toggle below to switch the contrast.

SCREEN READER

Listen to the content of the page by clicking play on ReadSpeaker.

Access

To discover more about accessibility, view our Accessibility Options here

Recall of Medical Products from API Source Nectar Lifesciences Ltd, Unit II, India/سحب المنتجات الطبية المصنعة من مصدر المادة الفعالة نكتار لايف ساينس ليمتد

29 Oct 2025

Reference: CIR-2025-00000197


 

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated.

 

Recall of Medical Products from API Source Nectar Lifesciences Ltd, Unit II, India

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

Supporting Documents:

icon

Recall of Medical Products from API Source Nectar Lifesciences Ltd, Unit II, India.pdf

icondownload

Do you find this Content helpful?

Close